NCT05259995View on ClinicalTrials.gov

Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 21, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Measurement of Diathermy on Anatomical Locations of the Body
Interventions
DEVICE

Sustained Acoustic Medicine

The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment.

Trial Locations (1)

06611

ZetrOZ, Trumbull

All Listed Sponsors
lead

ZetrOZ, Inc.

INDUSTRY